Enrich Therapeutics & Obsidian Advanced Manufacturing

Beacon Angels entertained the following new funding proposals at its meeting on March 10, 2020:

  • Enrich Therapeutics, which is developing a LCD-guided cell-isolation platform to enable life science research at the single-cell level; and
  • Obsidian Advanced Manufacturing, which offers a breakthrough method of printing micron-scale sensors, electromagnetics structures and radio-frequency devices directly on high-value assets.

We reviewed and discuss company updates including:

  • The exit of Concrete Sensors,
  • Funding a follow-on round of Xeno,
  • Funding a new round into Theromics, and
  • Completing the follow-on funding of Launchpad Medical.

About Beacon Angels

Angel group, founded in 2006, that invests in early stage start-up companies--New England based only.
This entry was posted in Beacon Angels Events, Boston angel investing, Boston Startups, Funding Presentations. Bookmark the permalink.